By visualizing DAT density in the striatum, dopaminergic imaging enables clinicians to differentiate PD from other conditions with similar clinical presentations, such as essential tremor and drug-induced parkinsonism (DIP), where DAT binding is preserved. Here, SLC6A3 is linked to Parkinson disease.